Bristol Pravigard PAC Set For August Launch At Pravachol AWP

Bristol-Myers Squibb will launch its pravastatin/aspirin combination Pravigard PAC in August at the same average wholesale price as the cholesterol-lowering agent Pravachol (pravastatin)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Pink Sheet